Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vojtech Melenovsky

Showing results (131-140 of 145) with videos related to

Pageof 15
Sort By:
Journal of Cachexia, Sarcopenia and Muscle|October 21, 2020
Dysregulation of epicardial adipose tissue in cachexia due to heart failure: the role of natriuretic peptides and cardiolipinPetra Janovska, Vojtech Melenovsky, Michaela Svobodova, et al.
Metabolism: Clinical and Experimental|December 5, 2025
Epicardial adipose tissue produces L-3-hydroxybutyrate in advanced heart failure: direct analysis of fat metabolic remodelingMartin Riecan, Barbora Judita Kasperova, Michaela Vondrackova, et al.
Circulation. Heart Failure|October 8, 2025
Phenomapping in Heart Failure With Reduced Ejection Fraction to Identify Subpopulations With High Residual Risk: A VICTORIA SubstudyPalak Shah, Yinggan Zheng, Burkert Pieske, et al.
Journal of the American College of Cardiology|September 1, 2024
Inflammation in Obesity-Related HFpEF: The STEP-HFpEF ProgramSubodh Verma, Mark C Petrie, Barry A Borlaug, et al.
JACC. Heart Failure|June 26, 2025
Diabetes Therapy With SGLT2i After Heart Transplant: A Multi-Institutional AnalysisLina Brinker, Konstantinos Sideris, Guo Wei, et al.
Cardiovascular Diabetology|June 29, 2024
Sodium-glucose cotransporter 2 inhibitors induce anti-inflammatory and anti-ferroptotic shift in epicardial adipose tissue of subjects with severe heart failureBarbora Judita Kasperova, Milos Mraz, Petr Svoboda, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 25, 2024
Redefining the molecular rejection states in 3230 heart transplant biopsies: Relationships to parenchymal injury and graft survivalPhilip F Halloran, Katelynn Madill-Thomsen, Arezu Z Aliabadi-Zuckermann, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 15, 2025
Defining the relationships among four tests for assessing antibody-mediated rejection in heart transplants in a prospective, observational studyKatelynn S Madill-Thomsen, Luis Guembes Hidalgo, Martina Mackova, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 22, 2026
A Two-Threshold dd-cfDNA Algorithm Improves Detection of Molecular Rejection in Heart TransplantationDr Philip F Halloran, Katelynn S Madill-Thomsen, D Giovanni Biagini, et al.
Journal of Cardiac Failure|September 19, 2024
Integration of Patient Reported Quality-of-life Data into Risk Assessment in Heart FailureKonstantinos Sideris, Mingyuan Zhang, Peter Wohlfahrt, et al.
Pageof 15

Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
Journal of Cachexia, Sarcopenia and Muscle|October 21, 2020
Dysregulation of epicardial adipose tissue in cachexia due to heart failure: the role of natriuretic peptides and cardiolipinPetra Janovska, Vojtech Melenovsky, Michaela Svobodova, et al.
Metabolism: Clinical and Experimental|December 5, 2025
Epicardial adipose tissue produces L-3-hydroxybutyrate in advanced heart failure: direct analysis of fat metabolic remodelingMartin Riecan, Barbora Judita Kasperova, Michaela Vondrackova, et al.
Circulation. Heart Failure|October 8, 2025
Phenomapping in Heart Failure With Reduced Ejection Fraction to Identify Subpopulations With High Residual Risk: A VICTORIA SubstudyPalak Shah, Yinggan Zheng, Burkert Pieske, et al.
Journal of the American College of Cardiology|September 1, 2024
Inflammation in Obesity-Related HFpEF: The STEP-HFpEF ProgramSubodh Verma, Mark C Petrie, Barry A Borlaug, et al.
JACC. Heart Failure|June 26, 2025
Diabetes Therapy With SGLT2i After Heart Transplant: A Multi-Institutional AnalysisLina Brinker, Konstantinos Sideris, Guo Wei, et al.
Cardiovascular Diabetology|June 29, 2024
Sodium-glucose cotransporter 2 inhibitors induce anti-inflammatory and anti-ferroptotic shift in epicardial adipose tissue of subjects with severe heart failureBarbora Judita Kasperova, Milos Mraz, Petr Svoboda, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 25, 2024
Redefining the molecular rejection states in 3230 heart transplant biopsies: Relationships to parenchymal injury and graft survivalPhilip F Halloran, Katelynn Madill-Thomsen, Arezu Z Aliabadi-Zuckermann, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 15, 2025
Defining the relationships among four tests for assessing antibody-mediated rejection in heart transplants in a prospective, observational studyKatelynn S Madill-Thomsen, Luis Guembes Hidalgo, Martina Mackova, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 22, 2026
A Two-Threshold dd-cfDNA Algorithm Improves Detection of Molecular Rejection in Heart TransplantationDr Philip F Halloran, Katelynn S Madill-Thomsen, D Giovanni Biagini, et al.
Journal of Cardiac Failure|September 19, 2024
Integration of Patient Reported Quality-of-life Data into Risk Assessment in Heart FailureKonstantinos Sideris, Mingyuan Zhang, Peter Wohlfahrt, et al.
Pageof 15